Does VORASIDENIB Cause Hepatic cytolysis? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Hepatic cytolysis have been filed in association with VORASIDENIB (VORANIGO). This represents 6.8% of all adverse event reports for VORASIDENIB.
18
Reports of Hepatic cytolysis with VORASIDENIB
6.8%
of all VORASIDENIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Hepatic cytolysis From VORASIDENIB?
Of the 18 reports.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VORASIDENIB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does VORASIDENIB Cause?
Alanine aminotransferase increased (33)
Fatigue (27)
Aspartate aminotransferase increased (26)
Malignant neoplasm progression (25)
Seizure (21)
Headache (17)
Hepatic enzyme increased (17)
Gamma-glutamyltransferase increased (16)
Nausea (16)
Hepatotoxicity (13)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which VORASIDENIB Alternatives Have Lower Hepatic cytolysis Risk?
VORASIDENIB vs VORETIGENE NEPARVOVEC-RZYL
VORASIDENIB vs VORICONAZOLE
VORASIDENIB vs VORINOSTAT
VORASIDENIB vs VORTIOXETINE
VORASIDENIB vs VORTIOXETINE HYDROBROMIDE